Inspire Medical Systems (INSP)
(Real Time Quote from BATS)
$212.22 USD
+0.12 (0.06%)
Updated Sep 20, 2024 11:24 AM ET
1-Strong Buy of 5 1
F Value A Growth C Momentum C VGM
Balance Sheet
Fiscal Year End for Inspire Medical Systems, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 460 | 451 | 214 | 234 | 149 |
Receivables | 90 | 61 | 34 | 25 | 13 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 34 | 12 | 17 | 8 | 6 |
Other Current Assets | 10 | 6 | 3 | 2 | 2 |
Total Current Assets | 594 | 530 | 269 | 270 | 171 |
Net Property & Equipment | 40 | 17 | 8 | 5 | 3 |
Investments & Advances | 9 | 0 | 10 | 0 | 6 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 11 | 11 | 0 | 0 | 0 |
Total Assets | 677 | 565 | 295 | 281 | 181 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 9 | 0 | 0 |
Accounts Payable | 39 | 27 | 12 | 7 | 4 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 39 | 34 | 20 | 14 | 12 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 78 | 61 | 41 | 21 | 17 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 16 | 25 | 25 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 1 | 0 | 0 | 0 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 104 | 69 | 66 | 51 | 41 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 917 | 820 | 508 | 467 | 320 |
Retained Earnings | -345 | -324 | -279 | -237 | -180 |
Other Equity | 1 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 573 | 496 | 229 | 230 | 140 |
Total Liabilities & Shareholder's Equity | 677 | 565 | 295 | 281 | 181 |
Total Common Equity | 573 | 496 | 229 | 230 | 140 |
Shares Outstanding | 29.50 | 28.80 | 27.30 | 26.90 | 24.00 |
Book Value Per Share | 19.41 | 17.22 | 8.39 | 8.54 | 5.83 |
Fiscal Year End for Inspire Medical Systems, Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 440 | 441 | 460 | 464 | 467 |
Receivables | 80 | 72 | 90 | 71 | 64 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 59 | 49 | 34 | 26 | 21 |
Other Current Assets | 29 | 10 | 10 | 8 | 9 |
Total Current Assets | 607 | 572 | 594 | 570 | 560 |
Net Property & Equipment | 62 | 52 | 40 | 32 | 25 |
Investments & Advances | 26 | 28 | 9 | 3 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 11 | 11 | 11 | 12 | 12 |
Total Assets | 728 | 686 | 677 | 639 | 618 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 34 | 44 | 39 | 40 | 40 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 32 | 28 | 39 | 30 | 27 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 66 | 72 | 78 | 70 | 67 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 1 | 0 | 0 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 90 | 97 | 104 | 95 | 89 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 984 | 944 | 917 | 904 | 881 |
Retained Earnings | -346 | -355 | -345 | -360 | -352 |
Other Equity | 0 | 0 | 1 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 638 | 589 | 573 | 544 | 529 |
Total Liabilities & Shareholder's Equity | 728 | 686 | 677 | 639 | 618 |
Total Common Equity | 638 | 589 | 573 | 544 | 529 |
Shares Outstanding | 29.70 | 30.30 | 29.50 | 29.30 | 29.30 |
Book Value Per Share | 21.48 | 19.44 | 19.41 | 18.57 | 18.07 |